Peritonitis: Difference between revisions

From IDWiki
No edit summary
()
 
(One intermediate revision by the same user not shown)
Line 15: Line 15:


===Peritoneal dialysis-related peritonitis===
===Peritoneal dialysis-related peritonitis===

* See [[peritoneal dialysis-associated peritonitis]]

== Differential Diagnosis ==

* [[Appendicitis]]
* [[Pneumonia]]
* [[Diabetic ketoacidosis]]
* [[Porphyria]]
* [[Familial Mediterranean fever]]
* [[Systemic lupus erythematosus]]
* [[Uremia]]


==Management==
==Management==
Line 23: Line 35:
**Broad-spectrum antibiotics
**Broad-spectrum antibiotics
**See also STOP IT trial for 4+/-1 days of antibiotics after source control[[CiteRef::sawyer2015tr]]
**See also STOP IT trial for 4+/-1 days of antibiotics after source control[[CiteRef::sawyer2015tr]]
*Associated with peritoneal dialysis: see [[Peritoneal dialysis-associated peritonitis#Management|peritoneal dialysis-associated peritonitis]]


[[Category:Intra-abdominal infections]]
[[Category:Intra-abdominal infections]]

Latest revision as of 14:48, 2 June 2021

Clinical Manifestations

Primary peritonitis

Secondary peritonitis

  • Secondary to surgery, trauma, or perforation

Tertiary peritonitis

Peritoneal dialysis-related peritonitis

Differential Diagnosis

Management

References

  1. ^  Robert G. Sawyer, Jeffrey A. Claridge, Avery B. Nathens, Ori D. Rotstein, Therese M. Duane, Heather L. Evans, Charles H. Cook, Patrick J. O’Neill, John E. Mazuski, Reza Askari, Mark A. Wilson, Lena M. Napolitano, Nicholas Namias, Preston R. Miller, E. Patchen Dellinger, Christopher M. Watson, Raul Coimbra, Daniel L. Dent, Stephen F. Lowry, Christine S. Cocanour, Michaela A. West, Kaysie L. Banton, William G. Cheadle, Pamela A. Lipsett, Christopher A. Guidry, Kimberley Popovsky. Trial of Short-Course Antimicrobial Therapy for Intraabdominal Infection. New England Journal of Medicine. 2015;372(21):1996-2005. doi:10.1056/nejmoa1411162.